Phase I study of [131I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol
出版年份 2022 全文链接
标题
Phase I study of [131I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol
作者
关键词
-
出版物
BMC CANCER
Volume 22, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-04-15
DOI
10.1186/s12885-022-09495-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Benzamide derivative radiotracers targeting melanin for melanoma imaging and therapy: Preclinical/clinical development and combination with other treatments
- (2021) Jacques Rouanet et al. PHARMACOLOGY & THERAPEUTICS
- Efficacy of Targeted Radionuclide Therapy Using [131I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant Melanoma
- (2021) Hussein Akil et al. Cancers
- Immune checkpoint inhibitors reverse tolerogenic mechanisms induced by melanoma targeted radionuclide therapy
- (2020) Jacques Rouanet et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Actualisation des données concernant le mélanome stade III : nouvelles recommandations du groupe français de cancérologie cutanée
- (2019) B. Guillot et al. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE
- Current and emerging systemic therapies for cutaneous metastatic melanoma
- (2019) Robert Mason et al. EXPERT OPINION ON PHARMACOTHERAPY
- Melanin presence inhibits melanoma cell spread in mice in a unique mechanical fashion
- (2019) Michal Sarna et al. Scientific Reports
- Targeted Radionuclide Therapy Decreases Melanoma Lung Invasion by Modifying Epithelial-Mesenchymal Transition-Like Mechanisms
- (2019) Hussein Akil et al. Translational Oncology
- Radiation dosimetry of [131 I]ICF01012 in rabbits: Application to targeted radionuclide therapy for human melanoma treatment
- (2018) Elodie Jouberton et al. MEDICAL PHYSICS
- Actualisation des recommandations de prise en charge du mélanome stades I à III
- (2016) B. Guillot et al. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE
- Targeted Radionuclide Therapy of Melanoma
- (2016) Abdullah Norain et al. SEMINARS IN NUCLEAR MEDICINE
- Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial
- (2015) Georgina V Long et al. LANCET
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
- (2014) Grant A McArthur et al. LANCET ONCOLOGY
- Evolutionary and biomedical consequences of internal melanins
- (2014) Sylvain Dubey et al. Pigment Cell & Melanoma Research
- In vivoefficacy of melanoma internal radionuclide therapy with a131I-labelled melanin-targeting heteroarylcarboxamide molecule
- (2013) Françoise Degoul et al. INTERNATIONAL JOURNAL OF CANCER
- MIRD Pamphlet No. 24: Guidelines for Quantitative 131I SPECT in Dosimetry Applications
- (2013) Y. K. Dewaraja et al. JOURNAL OF NUCLEAR MEDICINE
- Radiopharmaceutical Therapy of Patients with Metastasized Melanoma with the Melanin-Binding Benzamide 131I-BA52
- (2013) W. Mier et al. JOURNAL OF NUCLEAR MEDICINE
- 123I-BZA2 as a Melanin-Targeted Radiotracer for the Identification of Melanoma Metastases: Results and Perspectives of a Multicenter Phase III Clinical Trial
- (2013) F. Cachin et al. JOURNAL OF NUCLEAR MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-melanoma efficacy of internal radionuclide therapy in relation to melanin target distribution
- (2010) M. Bonnet et al. Pigment Cell & Melanoma Research
- Targeted radionuclide therapy of melanoma: Anti-tumoural efficacy studies of a new131I labelled potential agent
- (2009) Mathilde Bonnet-Duquennoy et al. INTERNATIONAL JOURNAL OF CANCER
- Evaluation of Radiolabeled (Hetero)Aromatic Analogues ofN-(2-diethylaminoethyl)-4-iodobenzamide for Imaging and Targeted Radionuclide Therapy of Melanoma
- (2008) Jean-Michel Chezal et al. JOURNAL OF MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now